Search

Your search keyword '"Eckhoff, Grace"' showing total 9 results
Start Over Author "Eckhoff, Grace"
9 results on '"Eckhoff, Grace"'

3. Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals

Author

Sarker, Suprovath Kumar, primary, Islam, Md Tarikul, additional, Eckhoff, Grace, additional, Hossain, Mohammad Amir, additional, Qadri, Syeda Kashfi, additional, Muraduzzaman, A. K. M., additional, Bhuyan, Golam Sarower, additional, Shahidullah, Mohammod, additional, Mannan, Mohammad Abdul, additional, Tahura, Sarabon, additional, Hussain, Manzoor, additional, Akhter, Shahida, additional, Nahar, Nazmun, additional, Shirin, Tahmina, additional, Qadri, Firdausi, additional, and Mannoor, Kaiissar, additional

Published
2016
Full Text
View/download PDF

4. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice

Author

Sayeed, Md. Abu, primary, Bufano, Meagan Kelly, additional, Xu, Peng, additional, Eckhoff, Grace, additional, Charles, Richelle C., additional, Alam, Mohammad Murshid, additional, Sultana, Tania, additional, Rashu, Md. Rasheduzzaman, additional, Berger, Amanda, additional, Gonzalez-Escobedo, Geoffrey, additional, Mandlik, Anjali, additional, Bhuiyan, Taufiqur Rahman, additional, Leung, Daniel T., additional, LaRocque, Regina C., additional, Harris, Jason B., additional, Calderwood, Stephen B., additional, Qadri, Firdausi, additional, Vann, W. F., additional, Kováč, Pavol, additional, and Ryan, Edward T., additional

Published
2015
Full Text
View/download PDF

5. Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide

Author

Alam, Mohammad Murshid, primary, Bufano, Megan Kelly, additional, Xu, Peng, additional, Kalsy, Anuj, additional, Yu, Y., additional, Freeman, Y. Wu, additional, Sultana, Tania, additional, Rashu, Md. Rasheduzzaman, additional, Desai, Ishaan, additional, Eckhoff, Grace, additional, Leung, Daniel T., additional, Charles, Richelle C., additional, LaRocque, Regina C., additional, Harris, Jason B., additional, Clements, John D., additional, Calderwood, Stephen B., additional, Qadri, Firdausi, additional, Vann, W. F., additional, Kováč, Pavol, additional, and Ryan, Edward T., additional

Published
2014
Full Text
View/download PDF

6. Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

Author

Leung, Daniel T., primary, Uddin, Taher, additional, Xu, Peng, additional, Aktar, Amena, additional, Johnson, Russell A., additional, Rahman, Mohammad Arif, additional, Alam, Mohammad Murshid, additional, Bufano, Meagan Kelly, additional, Eckhoff, Grace, additional, Wu-Freeman, Ying, additional, Yu, Yanan, additional, Sultana, Tania, additional, Khanam, Farhana, additional, Saha, Amit, additional, Chowdhury, Fahima, additional, Khan, Ashraf I., additional, Charles, Richelle C., additional, LaRocque, Regina C., additional, Harris, Jason B., additional, Calderwood, Stephen B., additional, Kováč, Pavol, additional, Qadri, Firdausi, additional, and Ryan, Edward T., additional

Published
2013
Full Text
View/download PDF

7. Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide.

Author

Alam, Mohammad Murshid, Bufano, Megan Kelly, Xu, Peng, Kalsy, Anuj, Yu, Y., Freeman, Y. Wu, Sultana, Tania, Rashu, Md. Rasheduzzaman, Desai, Ishaan, Eckhoff, Grace, Leung, Daniel T., Charles, Richelle C., LaRocque, Regina C., Harris, Jason B., Clements, John D., Calderwood, Stephen B., Qadri, Firdausi, Vann, W. F., Kováč, Pavol, and Ryan, Edward T.

Subjects
MICE, VACCINATION, VIBRIO cholerae, POLYSACCHARIDES, IMMUNOTHERAPY
Abstract

Background: Protective immunity against cholera is serogroup specific. Serogroup specificity in Vibrio cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. Methodology: Here we report the evaluation in mice of a conjugate vaccine for cholera (OSP:TThc) made from V. cholerae O1 Ogawa O-Specific Polysaccharide–core (OSP) and recombinant tetanus toxoid heavy chain fragment (TThc). We immunized mice intramuscularly on days 0, 21, and 42 with OSP:TThc or OSP only, with or without dmLT, a non-toxigenic immunoadjuvant derived from heat labile toxin of Escherichia coli. Principal Findings: We detected significant serum IgG antibody responses targeting OSP following a single immunization in mice receiving OSP:TThc with or without adjuvant. Anti-LPS IgG responses were detected following a second immunization in these cohorts. No anti-OSP or anti-LPS IgG responses were detected at any time in animals receiving un-conjugated OSP with or without immunoadjuvant, and in animals receiving immunoadjuvant alone. Responses were highest following immunization with adjuvant. Serum anti-OSP IgM responses were detected in mice receiving OSP:TThc with or without immunoadjuvant, and in mice receiving unconjugated OSP. Serum anti-LPS IgM and vibriocidal responses were detected in all vaccine cohorts except in mice receiving immunoadjuvant alone. No significant IgA anti-OSP or anti-LPS responses developed in any group. Administration of OSP:TThc and adjuvant also induced memory B cell responses targeting OSP and resulted in 95% protective efficacy in a mouse lethality cholera challenge model. Conclusion: We describe a protectively immunogenic cholera conjugate in mice. Development of a cholera conjugate vaccine could assist in inducing long-term protective immunity, especially in young children who respond poorly to polysaccharide antigens. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

8. Evaluation of a Novel Inaba Cholera Conjugate Vaccine in Mice

Author

Eckhoff, Grace

Abstract

Vibrio cholerae is a non-invasive Gram-negative enteric pathogen that causes cholera, a severe dehydrating diarrheal illness of humans. Cholera is responsible for substantial morbidity and mortality in both endemic and epidemic settings. Current oral killed vaccines do not provide protection that lasts as long as natural cholera infection, and current cholera vaccines have greatly reduced efficacy in children, the population most affected by cholera in endemic areas. Protection against cholera appears to be mediated by immune responses that target the O-specific polysaccharide (OSP) of V. cholerae. Here we report analysis of the immunogenicity and protective efficacy in mice of a cholera conjugate vaccine containing V. cholerae O1 Inaba OSP conjugated to a recombinant immunogenic fragment of tetanus toxoid heavy chain (rTTHc). OSP-rTTHc induced prominent anti-OSP responses in these animals. Serum from vaccinated mice also provide protection in the infant mouse model of cholera infection. Our results suggest that a cholera conjugate might have development potential for evaluation in humans.

Published
2015

9. Mass Treatment with Single-Dose Azithromycin for Yaws.

Author

Eckhoff, Grace, Eckhoff, Philip, Wood, Lowell, Mitjà, Oriol, Lukehart, Sheila, and Bassat, Quique

Subjects
*ANTIBIOTICS, *AZITHROMYCIN, *YAWS, *THERAPEUTICS
Abstract

A letter to the editor is presented in response to the article "Mass treatment with single-dose azithromycin for yaws" by O. Mitjà in the February 19, 2015 issue.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results